Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Recombinant dna technique included in method of making a...
Reexamination Certificate
2006-08-01
2006-08-01
Helms, Larry R. (Department: 1642)
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Recombinant dna technique included in method of making a...
C435S320100, C435S325000, C435S327000, C536S023100, C536S023500, C530S387200, C530S387300
Reexamination Certificate
active
07083943
ABSTRACT:
The present invention provides a monoclonal and-idiotype antibody 11D10 that elicits an immune response against a specific epitope of a high molecular weight mucin of human milk fat globule (HMFG) and a hybridoma that produces 11D10. The hybridoma that produces 11D10 was selected by specific procedures. 11D10 inducts an Immunological response to HMFG in mice, rabbits, monkeys and patients with advanced HMFG-associated tumors. This invention provides compositions derived from polynucleotide sequences encoding the variable light and/or variable heavy regions of monoclonal anti-idiotype antibody 11D10, as well as polypeptides encoded thereby. The invention also provides compositions which can be used in the detection or treatment of HMFG-associated tumors.
REFERENCES:
patent: 3996345 (1976-12-01), Ullman et al.
patent: 4436728 (1984-03-01), Ribi et al.
patent: 4675287 (1987-06-01), Reisfeld et al.
patent: 4683195 (1987-07-01), Mullis et al.
patent: 4683202 (1987-07-01), Mullis
patent: 4693966 (1987-09-01), Houghton et al.
patent: 4722840 (1988-02-01), Valenzuela et al.
patent: 4726947 (1988-02-01), Shimada et al.
patent: 4754065 (1988-06-01), Levenson et al.
patent: 4800159 (1989-01-01), Mullis et al.
patent: 4904596 (1990-02-01), Hakomori
patent: 4918164 (1990-04-01), Hellstrom et al.
patent: 5009995 (1991-04-01), Albino et al.
patent: 5053224 (1991-10-01), Koprowski et al.
patent: 5057540 (1991-10-01), Kensil et al.
patent: 5077284 (1991-12-01), Loria et al.
patent: 5091177 (1992-02-01), Hellstrom et al.
patent: 5134075 (1992-07-01), Hellstrom et al.
patent: 5171568 (1992-12-01), Burke et al.
patent: 5208146 (1993-05-01), Irie
patent: 5240833 (1993-08-01), Nudelman et al.
patent: 5242824 (1993-09-01), Hellstrom et al.
patent: 5270202 (1993-12-01), Raychaudhuri
patent: 5407684 (1995-04-01), Loria et al.
patent: 5808033 (1998-09-01), Gourlie et al.
patent: 5840299 (1998-11-01), Bendig et al.
patent: 6274143 (2001-08-01), Chatterjee et al.
patent: 0280209 (1988-08-01), None
patent: 0329400 (1993-09-01), None
patent: 0 438 803 (1997-03-01), None
patent: WO 86/00909 (1986-02-01), None
patent: WO 89/07268 (1989-08-01), None
patent: WO 89/11537 (1989-11-01), None
patent: WO 91/11465 (1991-08-01), None
patent: WO 91/16924 (1991-11-01), None
patent: WO 92/08495 (1992-05-01), None
patent: WO 92/16231 (1992-10-01), None
patent: WO 93/06233 (1993-04-01), None
patent: WO 94/05329 (1994-03-01), None
patent: WO 94/11508 (1994-05-01), None
Houdebine. Journal of Biotechnology 1994, 34: 269-287.
Verma et al. Nature 1997, 389: 239-242.
Amalfitano et al. Current Gene Therapy 2002, 2: 111-133.
Pandha et al. Current Opinion in Investigational Drugs 2000; 1 (1): 122-134.
Memorandum: Amy P. Patterson, MD, Department of Health and Human Services, Jan. 14, 2003, pp. 1-3.
Chakrabarti S, et al. Gene. Apr. 15, 1989; 77 (1): 87-93.
Herlyn, D, et al, 1995, Cloned antigens and antiidiotypes, Hybridoma, vol. 14, No. 2, pp. 159-166.
Zeytin, HE, et al, 2000, Construction and characterization of DNA vaccines encoding the single-chain variable fragment of the anti-idiotype antibody 1A7 mimicking the tumor-associated antigen GD2, Cancer Gene Therapy, vol. 7, No. 11, pp. 1426-1536.
Gavilondo, JV, et al, 2000, Antibody engineering at the millennium, Biotechniques, vol. 29, No. 1, pp. 128-145.
Editor, 1995, Instructions for authors, Cancer Research, vol. 55, No. 1, pp. 202-208.
Benvenuti, F, et al, 2001, Anti-idiotypic antibodies induced by genetic immunisation are directed exclusively against combined VL/VH determinants, Gene Therapy, vol. 8, No. 20, pp. 1555-1561.
Benvenuti, F, et al, 2000, Anti-idiotypic DNA vaccines for lymphoma immunotherapy require the presence of both variable region genes for tumor protection, Gene Therapy, vol. 7, No. 7, pp. 605-611.
Stevenson, FK, et al, 1995, Idiotypic DNA vaccines against B-cell lymphoma, Immunological Reviews, vol. 145, pp. 211-228.
Spooner, RA, et al, 1995, DNA vaccination for cancer treatment, Gene Therapy, vol. 2, No. 3, pp. 173-180.
Kennedy, RC, et al, 1985, Vaccines utilizing internal image anti-idiotypic antibodies that mimic antigens of infectious organisms, Biotechniques, vol. 3, No. 5, pp. 404-410.
Bodey, B, et al, 2000, Failure of cancer vaccines: the significant limitations of this approach to immunotherapy, Anticancer Research, vol. 20, pp. 2665-2676.
Browning et al Cell vol. 72 847-856, Mar. 1993.
Mo et al Eur J Immuno vol. 23 2503-2510, 1993.
Liu et a; J Immunology vol. 139(10) 3521-3526, Nov. 1987.
Chatterjee et al Cancer Immuno Immunother vol. 38 75-82, 1994.
Rudikoff et al Proc Natl Acad Sci USA vol. 79 1979, 1982.
Panka et al Proc Natl Acad Sci USA vol. 85 3080-3084, May 1988.
Amit et al Science vol. 233 747-753, 1986.
De Waele et al Eur J Biochem vol. 176 287-295, 1988.
Shlomchik et al J Exp Med vol. 171 265-297, Jan. 1990.
Kavaler et al J Immunology vol. 145 2312-2321 No. 7, Oct. 1990.
Seidman et al Nature vol. 280 370, Aug. 1979.
Darsley et al EMBO J vol. 4(2) 393-398, 1985.
Charkabroty et al Proc Amer Assoc Cancer Res vol. 35 p. 497 Abstract No. 2963, Mar. 1994.
Chatterjee et al Antigen and Antibody Molecular Engineering in Breast Cancer Diagnosis and Treatment 139-148, 1994.
Chakraborty et al J Immunotherapy vol. 18(2) 95-103, 1995.
Cancer Research, Jan. 1, 1995, vol. 55(1):pp. 202-208.
Altschul et al., “Basic local alignment search tool” (1990)J. Mol Biol. 215:403-410.
Barry et al., “Protection against mycoplasma infection using expression-library immunization” (1995)Nature 377:632-635.
Bhattacharya-Chatterjee et al., “Anti-idiotype antibodies as potential therapeutic agents for human breast cancer”Antigen and Antibody Molecular Engineering in Breast Cancer Diagnosis and Treatment, Eds. R.L. Ceriani (1994), pp. 139-148.
Bhattercharya-Chatterjee et al., “Idiotypic antibody immunotherapy of cancer” (1994)Cancer Immunol. Immunother. 38:75-82.
Bhattacharya-Chatterjee et al., “Idiotype vaccines against human T cell acute lymphoblastic leukemia” (1987)J. Immunol. 139:1354-1360.
Bhattacharya-Chatterjee et al., “Idiotype vaccines against human T cell leukemia”. II. Generation and characterization of a monoclonal idiotype cascade (Ab1, Ab2, and Ab3) (1988)J. Immunol. 141:1398-1403.
Bhattacharya-Chatterjee et al., “Murine monoclonal anti-idiotype antibody as a potential network antigen for human carcinoembryonic antigen” (1990)J. Immunol. 145:2758-2765.
Bird et al., “Single-chain antigen-binding proteins” (1988)Science 242:423-426.
Ceriani et al., “Characterization of cell surface antigens of human mammary epithelial cells with monoclonal antibodies prepared against human milk fat globule” (1983)Somatic Cell Genet. 9:415-427.
Ceriani et al., “Immunotherapeutic preclinical evaluation of anti-human mild fat globule MoAbs Mc5 and BrE-1” (1991)Antibody Immunoconjugates and Radiopharmaceuticals 3:181-198.
Ceriani et al., “Surface differentiation antigens of human mammary epithelial cells carried on the human mild fat globule” (1977)Proc. Natl. Acad. Sci. USA 74:582-586.
Chakraborty et al., “Immune responses in advanced breast cancer patients treated with an anti-idiotype antibody vaccine”, (1997)Amer. Acad. Canc. Res., Abstract (1 page total).
Chakraborty et al., “Induction of human breast cancer specific antibody responses in cynomolgus monkeys by a murine monoclonal anti-idiotype antibody”, (1995)Cancer Res. 55:1525-1530.
Chakraborty et al., “Induction of human breast cancer specific antibody responses in cynomolgus monkeys by a murine monoclonal anti-idiotype antibody”, (1994) Abstracts from proceedings of American Assoc. for Cancer Research vol. 35, Abstract No. 2963.
Chakraborty et al., “Preclinical evaluation in non-human primates of an anti-idiotypic antibody that mimicks that carcinoembryonic antigen”J. Immunother. (1995) 18:95-103.
Chatterjee et al., “Antiidiotype (Ab2) vaccine therapy for cutaneous T-cell lymphoma” (1993)Ann. N.Y. A
Chatterjee Malaya
Chatterjee Sunil K.
Foon Kenneth A.
Helms Larry R.
Morrison & Foerster / LLP
Rawlings Stephen L.
LandOfFree
Polynucleotides related to murine anti-idiotype antibody... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Polynucleotides related to murine anti-idiotype antibody..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polynucleotides related to murine anti-idiotype antibody... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3716774